Table 5.
Novel potential biomarkers for PanNENs diagnosis, prognosis and treatment monitoring.
Putative markers | Source | Level | Clinical use | References | ||
---|---|---|---|---|---|---|
Potentially Prognostic and/or Predictive | Delta-like protein 3 | DLL-3 | Surgical/endoscopic biopsy | Over-expressed | Potentially prognostic and therapeutic target | (236, 237) |
Tumor-Associated—Macrophages | TAMs | Surgical/endoscopic biopsy | Increased | Associated to reduced DSS | (61) | |
G protein coupled receptor-associated sorting protein 1 | GPRASP-1 | Serum | Down-regulated | Neuroendocrine de-differentiation | (235) | |
Glucose transporter 1 | GLUT-1 | Surgical/endoscopic biopsy | Over-expressed | Prognostic for higher metabolism and tumor aggressiveness | (90) |
PanNENs, Pancreatic Neuroendocrine Neoplasia; GEP-NENs, Gastro-Entero-Pancreatic Neoplasia.